HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment.

Abstract
Environmental temperature adversely affects the outcome of concussive head injury (CHI)-induced brain pathology. Studies from our laboratory showed that animals reared at either cold environment or at hot environment exacerbate brain pathology following CHI. Our previous experiments showed that nanowired delivery of oxiracetam significantly attenuated CHI-induced brain pathology and associated neurovascular changes. Military personnel are the most susceptible to CHI caused by explosion, blasts, missile or blunt head trauma leading to lifetime functional and cognitive impairments affecting the quality of life. Severe CHI leads to instant death and/or lifetime paralysis. Military personnel engaged in combat operations are often subjected to extreme high or low environmental temperature zones across the globe. Thus, further exploration of novel therapeutic agents at cold or hot ambient temperatures following CHI are the need of the hour. CHI is also a major risk factor for developing Alzheimer's disease by enhancing amyloid beta peptide deposits in the brain. In this review, effect of hot environment on CHI-induced brain pathology is discussed. In addition, whether nanodelivery of oxiracetam together with neprilysin and monoclonal antibodies (mAb) to amyloid beta peptide and p-tau could lead to superior neuroprotection in CHI is explored. Our results show that co-administration of oxiracetam with neprilysin and mAb to AβP and p-tau significantly induced superior neuroprotection following CHI in hot environment, not reported earlier.
AuthorsAla Nozari, Aruna Sharma, Zhenguo Wang, Lianyuan Feng, Dafin F Muresanu, Z Ryan Tian, José Vicente Lafuente, Anca D Buzoianu, Lars Wiklund, Hari Shanker Sharma
JournalAdvances in neurobiology (Adv Neurobiol) Vol. 32 Pg. 271-313 ( 2023) ISSN: 2190-5215 [Print] United States
PMID37480464 (Publication Type: Review, Journal Article)
Copyright© 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Chemical References
  • oxiracetam
  • Pyrrolidines
  • Neprilysin
  • Antibodies, Monoclonal
  • Amyloid beta-Peptides
  • tau Proteins
Topics
  • Brain Injuries, Traumatic (drug therapy, pathology)
  • Animals
  • Hot Temperature
  • Pyrrolidines (administration & dosage)
  • Humans
  • Nanowires (chemistry)
  • Brain (pathology)
  • Neprilysin (administration & dosage)
  • Antibodies, Monoclonal (administration & dosage)
  • Amyloid beta-Peptides (metabolism)
  • tau Proteins (metabolism)
  • Neuroprotection (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: